Indianapolis Business Journal

AUG. 18-24, 2023

A decade ago, Eli Lilly and Co. struggled to release new drugs and maintain investor interest. Today, the company is literally worth more than all of the gold in Fort Knox as its stock price continually posts new highs and analysts praise its pipeline of drugs. John Russell explores what this means for the company and Indianapolis. Also in this week’s issue, John Russell reports that one of the top researchers at Indiana University School of Medicine has been recruited away from the institution and taken more than two dozen faculty, postdoctoral associates and IU staffers with him. And Susan Orr highlights the fight against fake online consumer reviews and how the Federal Trade Commission wants to get involved.

Front PageBack to Top

Top StoriesBack to Top

Derek Schultz: The card king

Even on nonpromotion days, the past and present always intertwine at Indy Card Exchange, where generations of patrons consistently step through Albert’s door to pore over decades of collectible treasures—from MJ, to Mantle, to Mahomes.

Read More

Made in Indiana: Chocolate by DeBrand Fine Chocolates

History: DeBrand Fine Chocolates founder Cathy Brand-Beere grew up in a family deeply involved in confectionery arts. She began working with chocolate when she was 8. “I always loved the creative process of making fine chocolates and dreamt of opening a ‘real chocolate shop’ when I grew up,” she wrote on the company’s website. In […]

Read More

FocusBack to Top

OpinionBack to Top

In BriefBack to Top